Marsico Capital Management LLC lessened its position in shares of UnitedHealth Group Inc (NYSE:UNH) by 14.1% during the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 571,195 shares of the healthcare conglomerate’s stock after selling 93,838 shares during the quarter. UnitedHealth Group comprises about 6.0% of Marsico Capital Management LLC’s investment portfolio, making the stock its 7th largest position. Marsico Capital Management LLC owned approximately 0.06% of UnitedHealth Group worth $142,296,000 at the end of the most recent reporting period.
Other institutional investors and hedge funds have also recently modified their holdings of the company. Crewe Advisors LLC acquired a new position in shares of UnitedHealth Group during the fourth quarter valued at $25,000. Pearl River Capital LLC bought a new stake in UnitedHealth Group in the fourth quarter valued at about $35,000. Ipswich Investment Management Co. Inc. bought a new stake in UnitedHealth Group in the fourth quarter valued at about $40,000. OLD Second National Bank of Aurora increased its holdings in UnitedHealth Group by 70.0% in the fourth quarter. OLD Second National Bank of Aurora now owns 170 shares of the healthcare conglomerate’s stock valued at $42,000 after purchasing an additional 70 shares during the last quarter. Finally, Laurel Wealth Advisors LLC bought a new stake in UnitedHealth Group in the fourth quarter valued at about $42,000. 86.68% of the stock is currently owned by institutional investors and hedge funds.
In other UnitedHealth Group news, Director Gail R. Wilensky sold 2,930 shares of the stock in a transaction dated Thursday, March 14th. The stock was sold at an average price of $253.39, for a total value of $742,432.70. Following the completion of the sale, the director now directly owns 64,726 shares in the company, valued at $16,400,921.14. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Richard T. Burke sold 5,000 shares of the stock in a transaction dated Tuesday, March 12th. The stock was sold at an average price of $245.01, for a total value of $1,225,050.00. Following the completion of the sale, the director now owns 182,372 shares of the company’s stock, valued at $44,682,963.72. The disclosure for this sale can be found here. Insiders sold 17,930 shares of company stock valued at $4,587,133 over the last 90 days. Corporate insiders own 0.87% of the company’s stock.
A number of research firms recently commented on UNH. Morgan Stanley dropped their price objective on UnitedHealth Group from $315.00 to $285.00 and set an “overweight” rating for the company in a report on Wednesday. Barclays dropped their price objective on UnitedHealth Group from $290.00 to $270.00 and set an “overweight” rating for the company in a report on Wednesday. Zacks Investment Research upgraded UnitedHealth Group from a “hold” rating to a “buy” rating and set a $258.00 price objective for the company in a report on Wednesday. Citigroup dropped their price objective on UnitedHealth Group from $288.00 to $247.00 and set a “neutral” rating for the company in a report on Wednesday. Finally, SunTrust Banks dropped their price objective on UnitedHealth Group to $300.00 and set a “buy” rating for the company in a report on Wednesday. They noted that the move was a valuation call. One equities research analyst has rated the stock with a sell rating, one has assigned a hold rating, eighteen have assigned a buy rating and one has assigned a strong buy rating to the stock. The stock has a consensus rating of “Buy” and an average price target of $291.56.
Shares of UnitedHealth Group stock opened at $221.75 on Friday. UnitedHealth Group Inc has a 1 year low of $208.07 and a 1 year high of $287.94. The stock has a market capitalization of $212.78 billion, a price-to-earnings ratio of 17.22, a price-to-earnings-growth ratio of 1.18 and a beta of 0.79. The company has a quick ratio of 0.73, a current ratio of 0.73 and a debt-to-equity ratio of 0.64.
UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings results on Tuesday, April 16th. The healthcare conglomerate reported $3.73 earnings per share (EPS) for the quarter, topping the consensus estimate of $3.60 by $0.13. UnitedHealth Group had a return on equity of 24.38% and a net margin of 5.30%. The company had revenue of $60.30 billion during the quarter, compared to the consensus estimate of $59.72 billion. During the same period in the prior year, the company earned $3.04 earnings per share. The company’s revenue for the quarter was up 9.2% compared to the same quarter last year. On average, research analysts predict that UnitedHealth Group Inc will post 14.63 EPS for the current fiscal year.
ILLEGAL ACTIVITY NOTICE: “Marsico Capital Management LLC Sells 93,838 Shares of UnitedHealth Group Inc (UNH)” was reported by Zolmax and is the sole property of of Zolmax. If you are reading this report on another domain, it was illegally copied and republished in violation of U.S. and international copyright & trademark legislation. The correct version of this report can be read at https://zolmax.com/investing/marsico-capital-management-llc-sells-93838-shares-of-unitedhealth-group-inc-unh/3051897.html.
UnitedHealth Group Company Profile
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.
Further Reading: Price to Earnings Ratio (PE), For Valuing Stocks
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Inc (NYSE:UNH).
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.